Oxford Nanopore Technologies (LON:ONT) Reaches New 52-Week Low Following Analyst Downgrade

Shares of Oxford Nanopore Technologies plc (LON:ONT) hit a new 52-week low on Monday after Citigroup downgraded the stock to a buy rating. The stock traded as low as GBX 95.61 and last traded at GBX 99.19, with a volume of 10534120 shares trading hands. The stock had previously closed at GBX 120.30.

Separately, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a GBX 225 price target on shares of Oxford Nanopore Technologies in a research note on Tuesday, May 26th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of GBX 218.60.

Insider Buying and Selling at Oxford Nanopore Technologies

In related news, insider Nick Keher purchased 22,018 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were bought at an average price of GBX 113 per share, for a total transaction of £24,880.34. In the last quarter, insiders purchased 22,799 shares of company stock valued at $2,578,133. Corporate insiders own 2.54% of the company’s stock.

Oxford Nanopore Technologies Stock Performance

The company has a debt-to-equity ratio of 8.96, a current ratio of 3.56 and a quick ratio of 6.01. The business has a 50 day moving average price of GBX 123.34 and a 200 day moving average price of GBX 128.12. The stock has a market capitalization of £988.90 million, a PE ratio of -6.72 and a beta of 0.92.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.